Results 121 to 130 of about 14,252 (257)
Respirology, EarlyView.ABSTRACT Chronic obstructive pulmonary disease (COPD) remains the third leading cause of death worldwide, and conventional bronchodilator‐based therapies have limited efficacy in preventing exacerbations and disease progression. The 2024–2026 period represents a historic inflection point: three mechanistically distinct agents received Food and Drug ...
Naoya Fujino, Hisatoshi Sugiura
wiley +1 more source
Indian Journal of Allergy Asthma and Immunology, 2016 Objectives: Chronic obstructive pulmonary disease (COPD) and asthma are major concerns to health-care system. Improper inhaler device used (metered dose inhaler/dry powder inhaler) is one of the major causes associated with inadequate control of the ...
Akanksha Das +5 more
doaj +1 more source
Recent advances of non‐invasive sensors for smart wearable respiratory monitoring
VIEW, EarlyView.Respiration contains rich physiological and pathological information, making it one of the most fundamental and continuous vital signs. Respiration monitoring is a non‐invasive and simple, but incredibly powerful, tool for assessing health, managing disease, and tracking fitness.
Jianhui Chen +8 more
wiley +1 more source
Criminology, EarlyView.Abstract Discourse around drug policy presents a stark contrast between policing and harm reduction models, sparking debates on the state's regulatory versus protective role. Canada is an ideal case to study drug policy models due to its global recognition as a leader in harm reduction alongside continued reliance on policing of drugs.
Taylor Domingos
wiley +1 more source
Addiction, EarlyView.Abstract Background and Aims Psychedelic drugs may help treat alcohol use disorder (AUD). This study evaluated BPL‐003, a novel intranasal powder formulation of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) benzoate salt, in people with moderate–severe AUD enrolled in a standard of care, 10‐week programme of relapse‐prevention oriented Cognitive ...
John Marsden +10 more
wiley +1 more source
International Journal of COPD, 2021 Kai-Michael Beeh,1 Piotr Kuna,2 Massimo Corradi,3 Isabelle Viaud,4 Alessandro Guasconi,4 George Georges4 1Insaf Respiratory Research Institute, Wiesbaden, Germany; 2Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Łó
Beeh KM +5 more
doaj
Allergy, EarlyView.Healthcare systems contribute up to 5% of global GHG emissions, with inhalers contributing a proportion of these. The carbon footprint of current salbutamol inhalers (pMDI with HFA‐134a propellant and DPI) and a planned salbutamol pMDI with low‐GWP propellant HFA‐152a was quantified across seven countries.
James King +7 more
wiley +1 more source
International Journal of COPD, 2014 Gaetano Caramori,1 Kian Fan Chung,2 Ian M Adcock2 1Centro Interdipartimentale per lo Studio delle Malattie Infiammatorie delle Vie Aeree e Patologie Fumo-correlate (CEMICEF; formerly Centro di Ricerca su Asma e BPCO), Sezione di Medicina Interna e ...
Caramori G, Chung KF, Adcock IM
doaj
STUDI KELENGKAPAN PENJELASAN CARA PENGGUNAAN SEDIAAN CONTROLLER INHALER (KOMBINASI KORTIKOSTEROID DENGAN BETA-2 AGONIS) JENIS DISKUS® DAN TURBUHALER® OLEH APOTEKER DI APOTEK [PDF]
, 2016 Asthma is a chronic disease that can be controlled by treatment with a controller containing a corticosteroid combination with beta-2 agonists, which are available in the form Diskus® and Turbuhaler® which is DPI (dry powder inhaler) in Indonesia ...
Heru, Heru +3 more
core
Prediction of dry powder inhaler formulation performance from surface energetics and blending dynamics [PDF]
The Purpose of these studies was to investigate the ability of surface energy measurements and rates of mixing in dry powder inhaler formulations to predict aerosol dispersion performance.
Saleem, I, Smyth, H, Telko, M
core +1 more source